BioCentury
ARTICLE | Clinical News

Eloxatin oxaliplatin: Phase III data

June 7, 2004 7:00 AM UTC

In an international Phase III trial in 2,246 patients who had undergone curative resection for stage II or III colorectal cancer, the probability of disease-free survival at 3 years for those given fl...